Company Eidos Therapeutics, Inc.
Equities
EIDX
US28249H1041
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 16-02-29 |
Jonathan Fox
PSD | President | 67 | 16-09-30 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-05-31 |
Jonathan A. Barr
BRD | Director/Board Member | - | 21-01-25 |
Jonathan Fox
PSD | President | 67 | 16-09-30 |
Neil Kumar
CEO | Chief Executive Officer | 45 | 16-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,872,893 | 12,835,887 ( 33.02 %) | 0 | 33.02 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.97% | 103B | |
+6.97% | 101B | |
+4.40% | 23.07B | |
-11.95% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.74% | 16.94B | |
+5.79% | 14.07B | |
+37.79% | 12.35B |